Altamira Therapeutics Ltd. (CYTO)
NASDAQ: CYTO · Real-Time Price · USD
0.440
0.00 (-0.02%)
Nov 20, 2024, 4:00 PM EST - Market closed
Altamira Therapeutics Employees
Altamira Therapeutics had 10 employees as of December 31, 2023. The number of employees decreased by 6 or -36.20% compared to the previous year.
Employees
10
Change (1Y)
-6
Growth (1Y)
-36.20%
Revenue / Employee
n/a
Profits / Employee
-$259,700
Market Cap
1.50M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
China SXT Pharmaceuticals | 75 |
Helius Medical Technologies | 22 |
TFF Pharmaceuticals | 19 |
Tivic Health Systems | 9 |
Entero Therapeutics | 9 |
Revelation Biosciences | 9 |
Dermata Therapeutics | 8 |
SCWorx | 7 |
CYTO News
- 6 weeks ago - Altamira Therapeutics Provides Update on Nasdaq Listing - GlobeNewsWire
- 7 weeks ago - Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray - GlobeNewsWire
- 2 months ago - Altamira Therapeutics Ltd. (CYTO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results - GlobeNewsWire
- 2 months ago - Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024 - GlobeNewsWire
- 2 months ago - Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering - GlobeNewsWire
- 2 months ago - Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering - GlobeNewsWire
- 2 months ago - Altamira Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference September 9-11 - GlobeNewsWire